BIOTECH STARTUP BEHIND COVID-19 VACCINE DEVELOPED BY ASTRAZENECA FILES FOR US IPO

Highlights

• In a securities filing, Vaccitech PLC said it is planning to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, human papillomavirus and hepatitis B

• Vaccitech PLC was started by two scientists at the University of Oxford and had helped in the development of the coronavirus vaccine

The start-up named Vaccitech PLC behind the coronavirus vaccine join....